Ewing sarcoma is driven by the translocation of EWSR1 and members of the ETS transcription factors, most commonly FLI, giving rise to a fusion transcription factor oncoprotein that activates an aberrant transcriptional program29. Here, FLII is linked to Ewing sarcoma.